A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
Condition(s):Breast CancerLast Updated:April 10, 2012Terminated
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:April 10, 2012Terminated
Condition(s):Invasive Early Breast CancerLast Updated:January 22, 2014Terminated
Condition(s):Breast NeoplasmsLast Updated:July 20, 2010Completed
Condition(s):Breast CarcinomaLast Updated:June 22, 2016Unknown status
Condition(s):Endometrial CancerLast Updated:October 18, 2013Completed
Condition(s):Breast NeoplasmsLast Updated:November 19, 2013Terminated
Condition(s):Breast CancerLast Updated:December 18, 2008Terminated
Condition(s):HealthyLast Updated:July 5, 2019Withdrawn
Condition(s):Breast CancerLast Updated:October 8, 2015Completed
Condition(s):Breast NeoplasmsLast Updated:October 31, 2012Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.